Find out what GSK does and more about our products.We make sure our pricing is standardised and transparent for patients' best interest.Search for a job at GSK and apply. You are encouraged to report vaccine adverse events to the US Department of Health and Human Services. I n the US, i f you are a patient and have questions about our vaccines, please contact the GSK Response Center.
Below is an alphabetical list of the medicines and vaccines available in Pakistan.Everyone at GSK focuses on three priorities: Innovation, Performance, TrustGSK PakistanGlaxoSmithKline Pakistan Limited was created January 1st, 2001 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Wellcome (Pakistan) Limited and stands today as the largest pharmaceutical company in Pakistan.We are changing the way we work to further embed our values in everything we do.Certified Healthcare providers in Pakistan can find specific information on our products available in Pakistan by visiting health.gsk.pkTo ensure we can continue to deliver high quality products to patients and consumers in the future, we must protect the natural resources we need to make them today.Information regarding our codes of conduct, public policies and other reporting information.We make a wide range of medicines and vaccines. You can find an A-Z list of our vaccines available in the US below. Unfortunately, we cannot provide comprehensive information about our products on this website, in compliance with regulations. Our products are used by millions of people around the world, helping them to do more, feel better and live longer. Project SEARCH Our planet. The GSK IMPACT Awards have been running since 1997 and are designed to recognise and reward charities that are doing excellent work to improve people’s health. In October 2017, our shingles vaccine, Shingrix, received regulatory approval in Canada and the US. GSK is a science-led global healthcare company that researches and develops innovative healthcare products in the areas of Pharmaceuticals, Vaccines and Consumer Healthcare. We acquired Novartis’s vaccines business (excluding influenza vaccines) and combined our Consumer Healthcare businesses to create a new company. Below is an alphabetical list of the medicines and vaccines available in Pakistan.Our headquarters are in London and we employ over 99,000 people in 115 countries.We do not provide a comprehensive list of our products on this website as regulations restrict the information that a pharmaceutical company can provide about prescription medicines and vaccines.Stiefel has a long history of excellence in dermatology and deep expertise and R&D capabilities in acne, psoriasis, eczema, atopic dermatitis and superficial skin infections.Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world.As the integration of these business units progresses, this website will be updated to reflect the expanded portfolio of vaccines.We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.In March 2015 we completed a 3-part transaction with Novartis which reshaped our business. Visit www.vaers.hhs.gov to file a report, or call 1-800-822-7967. Discover how your career could help us improve the quality of human life.Find out how we are developing innovative products and improving quality of life for patients and consumers around the world.See what we're doing to fulfil our mission.Tell us about a possible side effect you may have experiencedFind out about how we conduct our clinical trials.Read our Annual Report and Responsible Business Supplement Everyone at GSK focuses on three priorities: Innovation, Performance, Trust Company Profile GSK Pakistan GlaxoSmithKline Pakistan Limited was created January 1st, 2001 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan (Private) Limited and Glaxo Wellcome (Pakistan) Limited and stands today as the largest pharmaceutical company in Pakistan. This site is intended for US healthcare professionals only. The business generated sales of £5.2 billion in 2017, representing 17% of the total turnover of the Group.